Clinical Trial Update: An Open-label Study of AZD0120 in Adults With Multiple Sclerosis [Phase 1]

View source ↗

Summary

This is an open-label Phase 1 clinical trial of AZD0120 in adults with Multiple Sclerosis. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• AZD0120

Snippet

Sponsor: AstraZeneca | Conditions: Multiple Sclerosis | Phase 1 | Status: RECRUITING